Table 1.
Dabigatran- and VKA-Matched–Treated Patients: Baseline Characteristics According to Treatment Group After Propensity Score Matching

Dabigatran- and VKA-Matched–Treated Patients: Baseline Characteristics According to Treatment Group After Propensity Score Matching
